News Articles on 'Medical Oncology'

Back to All Specialties


Medical World News: Managed Care Updates

such as the Oncology Care Model and oncology medical homes, which could have resulted in widespread improvements that simultaneously affect both ACO and non-ACO patients. “Although it may be too early to see an impact of ACOs on patients with cancer ...

Source: The American Journal of Managed Care
Published: 11 Dec 2018

Oncology market examined in new research report

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. It includes medical oncology the use of chemotherapy, hormone therapy, and other drugs to treat cancer, radiation oncology the use of radiation therapy to ...

Source: WhaTech
Published: 04 Dec 2018

ESMO Immuno-Oncology Congress showcases new technologies set to improve cancer treatment

This research will find a home in ESMO's Immuno-Oncology Technology Journal, which will educate medical oncologists so they are ready to use new drugs when they enter clinical practice." A wide range of promising technologies expected to become standard of ...

Source: EurekAlert!
Published: 11 Dec 2018

Center Will Be the First National-Scale Pediatric Oncology-Hematology Center in Georgia

program to U.S. nonprofit Global Healing and Tbilisi-based Jo Ann Medical Center (JAMC) to begin construction of the first national-scale pediatric hematology-oncology center in the Republic of ...

Source: GlobeNewswire
Published: 11 Dec 2018

Former CCS Oncology chief charged by Health Department in patient deaths

and its non-oncology branch, CCS Medical, shut down in April after FBI agents raided CCS locations in Erie and Niagara counties and after the practice filed for bankruptcy protection. The details ...

Source: The Buffalo News
Published: 06 Dec 2018

Getting the Patient's Viewpoint in the Oncology Quality Equation

According to Ana Maria Lopez, MD, MPH, vice chair of medical oncology and chief of the New Jersey Division of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, Pennsylvania, it may mean that physicians are using the classic ...

Source: The American Journal of Managed Care
Published: 11 Dec 2018

BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress

CAMBRIDGE, Mass., and BEIJING, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology ...

Source: Nasdaq
Published: 10 Dec 2018

New specialist equipment to double Wilgers Oncology Centre capacity

Lizl Page, Regional Business Manager for Medical Specialist Holdings (MSH), says the Wilgers Oncology Centre serves patients across a wide geographic area: “Besides the resident Alberts, Bouwer, Jordaan Inc. oncologists consulting in the centre ...

Source: Engineering News
Published: 12 Dec 2018

New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients

Contact: Laura D'Angelo pr@invitae.com (628) 213-3283 View original content to download multimedia:http://www.prnewswire.com/news-releases/new-study-published-in-journal-of-clinical-oncology-supports-universal-genetic-testing-for-all-breast-cancer-patients ...

Source: MarketWatch
Published: 10 Dec 2018

Sierra Oncology Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib

Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology. Our lead drug candidate, momelotinib, is a potent, selective and orally ...

Source: PR Newswire
Published: 03 Dec 2018

NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment

and INDIANAPOLIS, Dec. 3, 2018 /PRNewswire/ -- The National Comprehensive Cancer Network ® (NCCN ®) Oncology Research ... MD, Chief Medical Officer, NCCN. "The NCCN ORP facilitates clinical ...

Source: Yahoo Finance
Published: 03 Dec 2018

BRIEF-Aveo Oncology Collaborates With Astrazeneca

Dec 12 (Reuters) - Aveo Pharmaceuticals Inc: * AVEO ONCOLOGY ANNOUNCES IMMUNO-ONCOLOGY CLINICAL COLLABORATION WITH ASTRAZENECA * AVEO PHARMACEUTICALS INC - PHASE 1/2 STUDY WILL EVALUATE COMBINATION OF IMFINZI (DURVALUMAB) AND FOTIVDA (TIVOZANIB ...

Source: MSN
Published: 12 Dec 2018

Oncology Consultants Join Agendia's FLEX Big Data Registry Study, Helping to Build a Unique Resource for Breast Cancer Research

At Oncology Consultants, P.A., we are committed to doing everything we can to help advance our understanding of breast cancer and are proud to be the largest practice in Houston enrolling for this study." Dr. William Audeh, Chief Medical Officer at Agendia ...

Source: The Business Journals
Published: 04 Dec 2018

OncLive® to Present State of the Science Summit™ on Immunotherapy, Precision Medicine & Neuroscience in Oncology

Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology. Registration is free and open to all health care professionals, and food and beverages ...

Source: MarketWatch
Published: 04 Dec 2018

Radius Health (RDUS) Provides Updates on its Oncology Programs and Announces Scientific Presentations at SABCS

Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced updates from its oncology pipeline and its scientific ... therapies to treat serious conditions and fill unmet medical needs. “Elacestrant’s clinical profile to ...

Source: StreetInsider
Published: 30 Nov 2018

Top stories in hematology/oncology: FDA grants accelerated approval to leukemia drug, low-dose cisplatin beneficial in some patients with carcinoma

according to a study presented at the Palliative and Supportive Care in Oncology Symposium. Read more. Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness Healio spoke with a researcher from Harvard Medical School ...

Source: Healio
Published: 29 Nov 2018

Prostate Cancer International Appoints New Medical Director

He then completed his residency training in urology at Eastern Virginia Medical School in Norfolk, VA. After completing his fellowship in urologic oncology at the M. D. Anderson Cancer Center, in Houston, TX, he returned to Virginia Beach, VA, where he is ...

Source: UroToday
Published: 04 Dec 2018

Sabah to attract more medical tourists with first private Radiotheraphy and Oncology Centre

KOTA KINABALU: The state's first private Radiotheraphy and Oncology Centre was launched at the KPJ Sabah Specialist Hospital (KPJ Sabah) on Saturday (Dec 8). The ceremony was officiated by Sabah state secretary Datuk Seri Hashim Paijan, who was ...

Source: The Star Online
Published: 08 Dec 2018

Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology...

ALAMEDA, Calif., Dec. 12, 2018 /PRNewswire/ -- Magnetic Insight, Inc., a developer and manufacturer of transformational in vivo imaging platforms, announced a Series A financing led by 5AM Ventures. The proceeds will allow the company to expand the ...

Source: ADVFN
Published: 12 Dec 2018

Novocure (NVCR) Says Sub-Group Analysis of EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology

Novocure (NASDAQ: NVCR) announced today that the results of a retrospective post-hoc sub-group analysis of its EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma (GBM) have been published in the Journal of Neuro-Oncology. The analysis demonstrated ...

Source: StreetInsider
Published: 06 Dec 2018

Trianni licenses humanized model platform to MacroGenics for oncology research

The agreement with Trianni will support MacroGenics’ discovery programs for mAb therapeutics used in oncology. Ezio Bonvini, chief scientific officer of MacroGenics, said in a press release, that the company can use the mouse for its molecules that are ...

Source: Outsourcing-pharma
Published: 10 Dec 2018

Oncology infusion services available for Zachary-area cancer patients

the two organizations announced a new partnership to provide enhanced medical oncology care to Zachary-area cancer patients. Vince Cataldo, M.D., Joseph Shows, M.D. and Siva Yadlapati, M.D. have been providing medical oncology care at Lane Cancer Center ...

Source: WAFB
Published: 19 Nov 2018

New Doctor Joins Oncology Team at BMC Cancer Center

to the medical staff of Berkshire Medical Center and the physician staff of Hematology Oncology Services of BMC, located at the BMC Cancer Center. Dr. Fynan is accepting new patients in need of medical oncology services and joins doctors Michael DeLeo ...

Source: Iberkshires
Published: 28 Nov 2018

Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology

Response rate approximately doubled compared to previous studies with durvalumab alone in refractory head and neck cancer Danvatirsen, Ionis' most advanced Generation 2.5 antisense drug, demonstrated potential to treat intractable cancers CARLSBAD, Calif.

Source: Yahoo Finance
Published: 22 Oct 2018

Meet Matthew Matasar, Chief Of Medical Oncology At MSK Bergen

Matthew Matasar almost didn't become a doctor. The lymphoma specialist at Memorial Sloan Kettering Cancer Center (MSK) initially sought a career in philosophy, until he rethought the kind of ...

Source: USA Patch
Published: 10 Oct 2018

Immuno-Oncology Center's First Symposium Showcases Varied Research

Allison and Tasuku Honjo, as well as that of Yale’s Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology, and of medicine (medical oncology), who is credited with discovering ...

Source: medicine.yale.edu
Published: 23 Oct 2018

Clovis Oncology: Some Positives Emerge

Additional data from this TRITON2 study will be presented at this year's European Society for Medical Oncology conference in Germany that runs from October 19th through 23rd. This FDA action caused JPMorgan to reissue their Overweight rating on the stock ...

Source: Seeking Alpha
Published: 03 Oct 2018

LOXO's ESMO Update On Larotrectinib - Changing Treatment Paradigms

This update was presented on 10/21/18 at the European Society for Medical Oncology (ESMO) 2018 Congress. This analysis includes data from three separate studies: the Phase I trial in adults, the SCOUT pediatric phase I/II trial, and the Phase II NAVIGATE ...

Source: Seeking Alpha
Published: 25 Oct 2018

Yale Medical Oncology-Hematology Program

The Yale Medical Oncology-Hematology Fellowship Program is a 36-month training program that adheres to the ACGME and ABIM guidelines for combined training in Medical Oncology and Hematology. The fellowship program provides comprehensive clinical training ...

Source: medicine.yale.edu
Published: 25 Oct 2018